Nuvation Bio Inc (NUVB) concluded trading on Thursday at a closing price of $1.89, with 3.77 million shares of worth about $7.13 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -36.58% during that period and on March 06, 2025 the price saw a gain of about 1.07%. Currently the company’s common shares owned by public are about 335.25M shares, out of which, 226.09M shares are available for trading.
Stock saw a price change of -4.06% in past 5 days and over the past one month there was a price change of -21.58%. Year-to-date (YTD), NUVB shares are showing a performance of -28.95% which decreased to -10.85% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.67 but also hit the highest price of $4.16 during that period. The average intraday trading volume for Nuvation Bio Inc shares is 2.41 million. The stock is currently trading -11.45% below its 20-day simple moving average (SMA20), while that difference is down -22.36% for SMA50 and it goes to -31.23% lower than SMA200.
Nuvation Bio Inc (NYSE: NUVB) currently have 335.25M outstanding shares and institutions hold larger chunk of about 45.92% of that.
The stock has a current market capitalization of $638.00M and its 3Y-monthly beta is at 1.47. It has posted earnings per share of -$2.17 in the same period. It has Quick Ratio of 9.57 while making debt-to-equity ratio of 0.02. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for NUVB, volatility over the week remained 10.51% while standing at 6.58% over the month.
Stock’s fiscal year EPS is expected to rise by 73.34% while it is estimated to decrease by -3.11% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Jefferies on March 27, 2024 offering a Buy rating for the stock and assigned a target price range of between $1.40 and $10 to it. Coverage by BTIG Research stated Nuvation Bio Inc (NUVB) stock as a Buy in their note to investors on March 26, 2024, suggesting a price target of $5 for the stock. Stock get a Market perform rating from BMO Capital Markets on August 02, 2022.
